Works (1)

Updated: July 5th, 2023 15:54

2007 journal article

Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial

EUROPEAN HEART JOURNAL, 28(9), 1079–1084.

By: C. Miller*, A. Banerjee n, K. Mahaffey*, M. Kontos*, G. Fermann*, C. Pollack*, E. Antman*, P. Aylward* ...

author keywords: evolving myocardial infarction; troponin; initial treatment; outcomes
MeSH headings : Adrenergic beta-Antagonists / therapeutic use; Aged; Angioplasty, Balloon, Coronary / statistics & numerical data; Coronary Artery Bypass / statistics & numerical data; Female; Fibrinolytic Agents / therapeutic use; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction / blood; Myocardial Infarction / therapy; Platelet Aggregation Inhibitors / therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors; Recurrence; Treatment Outcome; Troponin / metabolism
TL;DR: Patients with EMI had lower rates of death or re-infarction at 30 days compared with patients presenting with positive troponin results and initial treatment patterns were similar among patients with E MI and MI in the SYNERGY trial. (via Semantic Scholar)
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.